Literature DB >> 6345610

Primary cutaneous malignant melanoma.

J C Maize.   

Abstract

The prognosis of localized malignant melanoma is related to several histologic features of the primary lesion. Growth pattern, level of invasion, and tumor thickness are currently most widely used in clinical practice, but other features, including ulceration, mitotic rate, density of the inflammatory response, evidence of partial regression, angioinvasion, cell type, cross-sectional profile, and amelanosis have been accorded prognostic significance in single factor analyses. Although stringently controlled prospective studies have yet to demonstrate the validity of these factors for the determination of optimal surgical treatment in individual cases, newer statistical methods of multivariate analysis have made possible assessment of the relative importance of each of these histologic characteristics. The most important and reproducible factor for predicting survival is maximum tumor thickness. Consensus also supports ulceration as another important, independent prognostic indicator, whereas growth pattern and level of invasion derive most of their prognostic value from a secondary correlation with tumor thickness. Mitotic rate may influence survival in the subgroup of patients with high-risk, thick melanomas.

Entities:  

Mesh:

Year:  1983        PMID: 6345610     DOI: 10.1016/s0190-9622(83)80017-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading.

Authors:  P Kaudewitz; O Braun-Falco; M Ernst; M Landthaler; W Stolz; J Gerdes
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

2.  Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes.

Authors:  S Ramon y Cajal; S Suster; R Halaban; E Filvaroff; G P Dotto
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.